Ulcerative colitis
Conditions
Interventions
None listed
Sponsors
Otsuka Pharmaceutical Factory, Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who can provide written informed consent
Exclusion criteria
Exclusion criteria: -
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The possible factors affecting postoperative adhesion and clinical outcomes, such as disease conditions of ulcerative colitis and preoperative medical treatments | — |
Countries
Japan
Contacts
Public ContactYoshihiro Kume
Otsuka Pharmaceutical Factory, Inc. Clinical Development Department, Research and Development Center
Outcome results
None listed